Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
83quz9FBCmLDXDdc